Clinical Trial Update: Dose Finding Study of Nimodipine for the Treatment of Progranulin Insufficiency From GRN Gene Mutations [Phase 1]

View source ↗

Summary

Phase 1 dose-finding trial of nimodipine for progranulin insufficiency due to GRN mutations has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Frontotemporal Dementia

Drugs mentioned

• Nimodipine (Nimodipine)

Snippet

Sponsor: University of California, San Francisco | Conditions: Progranulin Mutation Carriers | Phase 1 | Status: COMPLETED